Results for tag: "Daunorubicin"

Daunorubicin is an oncology drug used to treat a variety of cancers, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and non-Hodgkin's lymphoma. It is a type of anthracycline antibiotic, derived from Streptomyces peucetius, and works by interfering with the growth of cancer cells. Daunorubicin is administered intravenously, and is often used in combination with other chemotherapy drugs. Daunorubicin is a widely used drug in the oncology market, and is often prescribed as a first-line treatment for AML and ALL. It is also used in combination with other drugs to treat other types of cancer, such as breast cancer and ovarian cancer. Daunorubicin is generally well-tolerated, but can cause side effects such as nausea, vomiting, and hair loss. Some companies in the daunorubicin market include Pfizer, Bristol-Myers Squibb, and Teva Pharmaceuticals. Show Less Read more